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ABSTRACT
Group 1 metabotropic glutamate receptors (mGluR1 and mGluR5) are G-protein coupled
receptors (GPCRs) activated by glutamate. mGluR1/5 couples to Gαq/11 and releases Ca2+
from the endoplasmic reticulum. Ca2+/calmodulin-dependent protein kinase II alpha
(CaMKIIα) can be activated by Gαq/11-mediated Ca2+ release through binding of
Ca2+/calmodulin. Results from a proteomic screen identified CaMKII as a novel mGluRinteracting protein. Therefore, we hypothesized that CaMKIIα associates with group 1
mGluRs and this association alters mGluR1/5 signalling and internalization. Firstly, we
demonstrated the novel association between CaMKIIα and mGluR1/5 by coimmunoprecipitation of transiently transfected proteins in HEK293 cells and of
endogenous proteins in mouse hippocampal tissue. Next, we showed that the second
intracellular loop of the mGluR1a receptor is sufficient for this association. Furthermore,
CaMKIIα significantly enhances agonist-induced internalization of group 1 mGluRs. Yet,
it does not appear that CaMKIIα plays a significant role in receptor signalling by either
ERK1/2 phosphorylation or inositol phosphosphate formation. Both CaMKIIα and
mGluR1/5 play an important role in memory, learning and synaptic transmission.
Understanding how these two players work together could provide a mechanism for
reducing excitotoxicity through desensitization of mGluR1/5 by CaMKIIα.
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CHAPTER 1
INTRODUCTION

1.1 G protein-coupled receptors
G protein-coupled receptors (GPCRs) are seven transmembrane (7TM) embedded
receptors that respond to a wide variety of stimuli: odor, taste, light, hormones and
neurotransmitters. These extracellular signals are relayed by coupling of GPCRs to
heterotrimeric guanine nucleotide-binding proteins (G proteins). Activated G proteins then
mediate downstream effector pathways through second messengers. GPCRs are the target
of over 50% of all prescription drugs and yet only approximately 4% of GPCRs are
currently targeted (Tyndall Jd and Sandilya R, 2005). Therefore, GPCRs are a key area of
research for expanding the understanding and treatment of diseases. There are six
subfamilies within the GPCR superfamily: Class A of rhodopsin-like receptors; Class B
includes secretin receptors; Class C, also called glutamate family, includes metabotoropic
glutamate receptors (mGluR), GABAB and Ca2+ sensing receptors; Class D of pheromone
receptors; Class E of cAMP receptors and Class F of frizzled and smoothened receptors
(Kolakowski; Lagerström and Schiöth, 2008). Class C receptors and specifically mGluRs
will be the focus of this thesis. This class of receptors bears little sequence homology and
is structurally distinct from prototypic GPCRs (Chun et al., 2012).
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1.2 Metabotropic glutamate receptors
Glutamate is the major excitatory neurotransmitter in the central nervous system
(CNS). It functions in learning and memory as well as neurodegenerative disorders
(Fonnum, 1984; Lau and Tymianski, 2010; Nakanishi, 1992). Glutamate signals are
received at the post-synaptic membrane by two types of receptors: ionotropic and
metabotropic. N-methyl-D-aspartate receptor (NMDAR), α-amino-3-hydroxy-5-methyl-4isoxazolepropionic acid receptor (AMPAR), and kainate receptors are all ionotropic
receptors, which respond to agonist stimulation by opening cation channels. mGluRs are
GPCRs that mediate changes in the post-synaptic cell through second messenger signalling
pathways (Figure1.1) (Conn and Pin, 1997; Nakanishi, 1992).
There are eight mGluRs, which are grouped into three subclassifications by
sequence homology and G protein coupling (Conn and Pin, 1997; Ferraguti and
Shigemoto, 2006). Group 1 mGluRs (mGluRs 1 and 5) activate phospholipase Cβ through
coupling to Gαq/11, while groups 2 and 3 mGluRs (mGluRs 2 and 3; mGluRs 4,6,7, and 8
respectively) negatively regulate adenylyl cyclase though coupling to Gαi/o. It is group 1
mGluRs, which will be the focus of this project. mGluR5 was discovered and characterized
after mGluR1 (Abe et al., 1992). At this time, it was grouped together with mGluR1
because of its similarities in sequences and ligand specificity. These receptors are
endogenously activated by glutamate or synthetic analog quisqualate and are specifically
activated by (S)-3,5-dihydroxyphenylglycine (DHPG). Agonist activation of group 1
mGluRs signals through Gαq/11 to mediate intracellular Ca2+ release (Mizuno and Itoh,
2009).

2

Figure 1.1. Glutamate receptor-mediated calcium release at the synapse. Glutamate
interacts with both ionotropic glutamate receptors (iGluRs), NMDAR, AMPAR and
Kainite-R, as well as group 1 metabotropic glutamate receptors (mGluRs), mGluR1 and
mGluR5, to mediate increased intracellular Ca2+ upon glutamate stimulation. iGluRs
respond to agonist stimulation through the opening of cation channels. Extracellular Ca2+
then flows according to its gradient into the cell through these channels. mGluR1/5 couples
to Gαq/11, which stimulates phospholipase Cβ to hydrolyze phophatydylinositol
bisphosphate into second messengers: diacylglyceral (DAG) and inositol-1,4,5trisphosphate (IP3). IP3 releases Ca2+ from endoplasmic reticulum by activating the IP3
receptor. (Dhami and Ferguson, 2006)
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1.2.1 Structure and functional domains
There are four known splice variants of mGluR1 (a, b, c, and d) and two known of
mGluR5 (a and b). mGluR1a has the longest carboxyl-terminal tail (318 amino acids),
while mGluR1b, 1c, and 1d have shorter tails (20, 11 and 26 amino acids in length) (Conn
and Pin, 1997; Pin et al., 1992; Tanabe et al., 1992). Therefore, mGluR1a is more efficient
in coupling with Gαq/11 as compared to the shorter carboxyl-terminal tail variants (Pin et
al., 1992; Prézeau et al., 1996). mGluR5 variants also vary in C-terminal tail length 5a with
32 amino acids and 5b with 50 amino acids (Joly et al., 1995). My project focuses on
mGluR1a and mGluR5a.
Unlike prototypic GPCR agonists, glutamate, is not bound in a pocket formed by
the 7TMs, but instead by the extracellular N-terminal domain, which makes a ‘clam-shell’
like shape, also known as the venus fly trap model (Kunishima et al., 2000; Niswender and
Conn, 2010). This large extracellular domain is also required for receptor dimerization
(Beqollari and Kammermeier, 2010). More specifically, the receptors form a homodimer
through covalent linkage at the receptor’s Cys 140 residue. Group 1 mGluRs, especially
mGluR1a, have a large intracellular C-terminal tail domain important for receptor
scaffolding as it contains the Homer binding domain and the PDZ binding domain
(reviewed in (Enz, 2012; Magalhaes et al., 2012; Ritter and Hall, 2009).
For prototypic GPCRs, the third intracellular loop (IL-3) is important for G protein
selectivity (Blüml et al., 1994). However, the IL-3 region of mGluRs is highly conserved
and, therefore, not likely responsible for G protein selectivity. Instead, the IL-2 has been
implicated as a key player in G protein selectivity because it is highly variable among
subtypes of mGluRs, thus allowing for different G protein selectivity among subtypes
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(Gomeza et al., 1996; Niswender and Conn, 2010). Furthermore, experimental evidence
has confirmed that the IL-2 of the mGluR1/5 is involved in G protein coupling (along with
the IL-3 and C-terminal tail) (Francesconi and Duvoisin, 1998; Hermans and Challiss,
2001). Francesconi and Duvoisin (1998) isolated specific domains in the IL-2 that were
important for Gαq selectivity (Thr 695, Lys 697 and Ser 702) and Gαs selectivity (Pro 698,
Cys 694-Thr 695). Our lab has also shown that the IL-2 interacts with CAIN (Ferreira et
al., 2009), Pyk2 (Nicodemo et al., 2010) and is also the primary binding site of GRK2
(Dhami et al., 2004).

1.2.2 Cellular and subcellular distribution
Group 1 mGluRs, mGluR1 and mGluR5, have distinct expression patterns in the
CNS, which yields an anatomical basis for their divergent functions (see Ferraguti and
Shigemoto (2006) for a review). mGluR5 is highly expressed throughout the hippocampus,
especially in the CA1 and CA3 pyramidal cells and the granular cells of the dentate gyrus
(Shigemoto et al., 1997). Some isoforms of mGluR1 are expressed in the CA3 pyramidal
cells and the granular cells of the dentate gyrus. However, mGluR1a is expressed mostly in
the CA1 interneurons of the hippocampus (Shigemoto et al., 1997) and is essential for
long-term potentiation initiation in these interneurons (Lapointe et al., 2004; Perez et al.,
2001). mGluR1a is highly expressed in the Purkinje cells of the cerebellar cortex, where
mGluR1a is required for long-term depression (LTD) and motor coordination (Ichise et al.,
2000). Comparatively, mGluR5 is not expressed in the Purkinje cells and is expressed only
in a small portion of the Golgi cells in the cerebellar cortex (Négyessy et al., 1997).
Expression of mGluR5 is much higher than mGluR1 in both the cortex (Romano et al.,
1995) and the striatum (Ribeiro et al., 2010). Research from our lab suggested that
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mGluR5 desensitization in the striatum plays a neuroprotective role in the early,
asymptomatic phase of Huntington’s disease and a neurotoxic role in later stages of the
disease (Ribeiro et al., 2010; Ribeiro et al., 2011). In general, mGluRs are expressed in the
neuronal cells of the CNS, however some expression of mGluR5 has been found in
astrocytes (Balázs et al., 1997).
At the synapse, group 1 mGluRs are located predominately post-synaptic just
outside of the post-synaptic density (López-Bendito et al., 2002; Lujan R., 1996;
Shigemoto et al., 1997). This makes mGluR1/5 particularly attractive for the study of postsynaptic modification and synaptic plasticity. Overall, group 1 mGluRs are usually
localized to somatodendritic regions of neurons. However, this expression pattern is altered
in multiple sclerosis (MS) (Geurts et al., 2003). Geurts et al. revealed heightened mGluR1a
expression in neuronal axons both in lesions and in normal appearing white matter of MS
brains, suggesting a possible role for mGluRs in MS pathology. Localization of mGluRs in
the CNS is important for understanding their role in normal neuronal functioning as well as
the aberrant localization that can contribute to disease pathology.

1.2.3 G protein coupling and effector signalling
Group 1 mGluRs are coupled predominately to Gαq/11, which will be the focus of
this thesis (Gαq/11 signalling is reviewed in Mizuno and Itoh (2009)). mGluR1a can also
couple to other G proteins (Gαs and Gαi/o) and stimulate adenylate cyclase, which catalyzes
the conversion of adenosine triphosphate (ATP) to cyclic adenosine monophosphate
(cAMP) (Francesconi and Duvoisin, 1998); conversely, mGluR5a does not stimulate the
cAMP pathway (Abe et al., 1992). Agonist binding to mGluR1/5 stabilizes the receptor
conformation that promotes the exchange of GDP to GTP on the Gα subunit of the
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heterotrimeric G protein. This allows Gα-GTP and Gβγ subunits to dissociate and activate
effector

enzymes.

phosphatidylinositol

Gαq/11

activates

phospholipase

4,5-bisphosphate (PIP2)

Cβ

(PLC-β)

producing two

to

second

hydrolyze
messengers:

diacylglyceral (DAG) and inositol 1,4,5-trisphosphate (IP3). DAG activates protein kinase
C (PKC) and IP3 releases Ca2+ from the IP3-regulated intracellular stores such as the
endoplasmic reticulum. Group 1 mGluR coupling to heterotrimeric Gαq/11 activates effector
proteins such as protein kinase C (PKC), Ca2+/calmodulin-dependent protein kinase II
(CaMKII), extracellular signal-regulated kinase (ERK), and proline-rich tyrosine kinase 2
(Pyk2) (Choe and Wang, 2001; Mockett et al., 2011; Nicodemo et al., 2010).
Receptor subtypes express different signal patterning, which can lead to divergent
downstream signalling of mGluR-1 and -5. Oscillatory mGluR1/5 coupling to Gαq/11 and
activation of PLC causes oscillations in IP formation, Ca2+, and PKC activation (Dale et
al., 2001a; Kawabata et al., 1998). Both Ca2+ and PKC oscillations are distinct between
mGluR1 and mGluR5. mGluR1a-mediated Ca2+ oscillations are lower in frequency when
compared to mGluR5a oscillations (Kawabata et al., 1998). Oscillations of Ca2+ are
important for activation of downstream effector proteins such as CaMKII (Bayer et al.,
2002; Chao et al., 2011; Koninck, 1998) and PKC. PKC oscillations are distinct between
receptor subtypes mGluR1a and -5a. A single residue in the G protein-coupling domain
regulates this receptor subtype specific pattern of PKC oscillation (Dale et al., 2001a).

1.2.4 Activation of mitogen-activated protein kinases
Activation of group 1 mGluRs stimulates the mitogen-activated protein kinase
(MAPK) pathway specifically the phosphorylation of extracellular regulated kinase 1 and 2
(ERK1/2) (Choe and Wang, 2001; Ferraguti et al., 1999; Karim et al., 2001). Once
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activated, EKR1/2 translocates to the nucleus where it facilitates gene expression through
regulation of specific transcription factors, thereby effecting long-term changes in the CNS
at the cellular level. ERK1/2 activation can promote cell protection or cell death pathways
depending on the level and duration of stimulation (reviewed in (Agell et al., 2002;
Mebratu and Tesfaigzi, 2009). There is still much to discover about mGluR-mediated
ERK1/2 phosphorylation. To date there are a number of molecular pathways that have
been shown to contribute to mGluR-mediated ERK1/2 phosphorylation (reviewed in Wang
et al. (2007)). mGluR-mediated activation can occur via by both G protein-dependent and independent mechanisms. In terms of G protein-dependent mechanism, studies have found
that mGluR1a (Ferraguti et al., 1999) and mGluR5 (Chen et al., 2012) activate ERK in a
PKC dependent manner. Conversely, Mao et al. (2005) found that IP3 and Ca2+ and not
DAG and PKC were important for some forms of ERK activation by mGluR5. In addition
to this G protein-dependent mechanism, Mao et al. goes on to describe a second
mechanism that accounts for a greater amount of ERK1/2 activation. This mechanism is G
protein-independent and requires Homer1b/c (Mao et al., 2005). In addition, mGluRs
appear to signal through receptor tyrosine kinases as well as non-receptor tyrosine kinases
(reviewed in Wang et al. (2007)). Our lab found that Pyk2, a non-receptor tyrosine kinase,
associates

with

mGluR1a’s

second

intracellular

loop

and

facilitates

ERK1/2

phosphorylation (Nicodemo et al., 2010). Pyk2 activates ERK1/2 in a PKC-, calmodulinand Src-dependent manner. Emery et al. (2010) described a G protein- and PLCindependent mechanism of ERK phosphorylation by mGluR1a. This requires β-arrestin-1
and Dynamin, which suggests there may be a role for the internalization of mGluR1 by βarrestin in ERK activation. This mechanism produces sustained ERK phosphorylation,

8

compared to a transient form accounted for by G protein-dependent mechanisms.
Furthermore, this group elucidated a ligand bias whereby glutamate, not quisqualate nor
DHPG, activates the G protein-independent ERK activation pathway (Emery et al., 2012;
Emery et al., 2010). Emery suggests that it is this sustained ERK activation and not the
transient G protein-dependent ERK activation that has a neuroprotective quality.
Moreover, ERK1/2 activation is required for mGluR-mediated LTD. ERK1/2 regulates the
initiation of protein translation in many cell types and is thus thought to play a central role
in expression of mGluR-mediated LTD through protein translation (Gallagher et al., 2004;
Volk et al., 2006).

1.3 GPCR desensitization and endocytosis
Receptor desensitization is a protective mechanism from over stimulation and
potential neuronal death by excitotoxicity. Neurodegenerative diseases such as
Amyotrophic Lateral Sclerosis, Alzheimer’s Disease, Multiple Sclerosis and Huntinton’s
Disease are all mediated in part by excitotoxicity (D'Antoni et al., 2011; Geurts et al.,
2003; Ribeiro et al., 2010). That desensitization is a naturally occurring neuroprotective
mechanism makes it an exciting field of study for development of disease treatment.
Desensitization is a feedback mechanism whereby excessive acute or chronic over
stimulation leads to a reduced receptor response over time. The mechanism of GPCR
desensitization can occur within seconds of agonist stimulation beginning with
phosphorylation of the receptor, within minutes the receptor can internalize and within
hours it can be down regulated. The extent of receptor desensitization depends on the level
and duration of agonist stimulation as well as fine-tuning by receptor interacting proteins
(reviewed in Ferguson, 2001; Kelly et al., 2008).
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The prototypic model of GPCR desensitization (Figure 1.2) begins with receptor
phosphorylation, which promotes uncoupling of the G protein from the receptor. Serine
and threonine residues within the intracellular loops and C-terminal tail are
phosphorylated. This receptor phosphorylation can be accomplished by second messengerdependent protein kinases, protein kinase C (PKC) and cAMP-dependent protein kinase
(PKA), or G protein-coupled receptor kinases (GRKs) (Benovic et al., 1985; Benovic et al.,
1986). Homologous (agonist-dependent) desensitization refers to reduced response from
the stimulated receptor, whereas heterologous (agonist-independent) desensitization occurs
when the stimulation of one receptor leads to the reduced response in another receptor.
Second messenger-dependent protein kinases phosphorylate receptors regardless of
receptor conformation and can contribute to both agonist-dependent and -independent
desensitization (Clark et al., 1988; Kelly et al., 2008). Conversely, GRKs selectively
phosphorylate receptors in the agonist-activated conformation, and are implicated in
homologous desensitization (Benovic et al., 1986). β-arrestins preferentially bind to GRKphosphorylated receptors more so than unphosphorylated or second messenger
phosphorylated (Ferguson et al., 1996; Lohse et al., 1992). Binding of β-arrestins furthers
desensitization in two main ways: it sterically uncouples the receptor from the G protein
and promotes internalization by recruiting clathrin and β2-adaptin, which facilitates
endocytosis by clathrin-coated pits (Zhang et al., 1996). Internalized receptors then
undergo resensitization or down regulation. Resensitized receptors are dephosphorylated
and recycled back to the cell surface. Down regulation involves the reduction of the cell’s
receptor inventory through proteolytic degradation of existing receptors and reduced gene
expression (Ferguson, 2001; Kelly et al., 2008; Ritter and Hall, 2009).
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Figure 1.2. Prototypic model of GPCR desensitization. Receptor desensitization begins
when the receptor is phosphorylated by second messenger dependent protein kinases, like
protein kinase C (PKC), or G protein-coupled Receptor Kinases (GRKs). This is followed
by β-arrestin binding, which promotes G protein uncoupling. β-arrestin recruits clathrin
and β2-adaptin, facilitating endocytosis by clathrin coated pits. (Ferguson, 2001; Dhami
and Ferguson, 2006; Ritter and Hall, 2009)
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1.3.1 Group 1 mGluR desensitization and endocytosis
mGluRs are structurally and functionally distinct from other GPCRs. Likewise, the
mechanism of mGluR desensitization and endocytosis is also distinct. mGluRs are able to
undergo both phosphorylation-dependent and -independent desensitization (reviewed in
Dhami and Ferguson (2006)). PKC contributes to desensitization of group 1 mGluRs by
direct phosphorylation of the receptor (Gereau and Heinemann, 1998; Herrero et al., 1994;
Mundell et al., 2002). For mGluR5, two residues in the C-terminal tail, Ser 881 and Ser
890, seem to be especially important for PKC-mediated desensitization (Gereau and
Heinemann, 1998). For mGluR1, PKC-mediated desensitization occurs by phosphorylation
of Thr 695 in the second intracellular loop, which disrupts the Gαq/11 pathway while having
no effect on the Gαi/o (Francesconi and Duvoisin, 2000). In addition to PKC, Optineuron
(Anborgh et al., 2005), PKA (Mundell et al., 2004) and CaMKIIα (Mundell et al., 2002)
have been shown to contribute to mGluR desensitization and internalization. Furthermore,
many GRK isoforms have been shown to mediate desensitization of mGluR1 (Dale et al.,
2000; Sallese et al., 2000). Sallese et al. 2000 found that GRK4 contributed to mGluR1a
desensitization and internalization in HEK293 cells and cultured Purkinje cells. Dale et al.
(2000) found that in HEK293 cells GRK2 and 5 contributed to mGluR1a desensitization
and internalization and that this process can protect against cell death.
GRK2-mediated mGluR1 desensitization departs from the prototypic model of
receptor desensitization as it can be mediated via a β-arrestin and phosphorylation
independent mechanism. β-arrestin is not required for mGluR1a desensitization; however,
it is required for mGluR1a agonist-dependent internalization (Dale et al., 2001b).
Phosphorylation-independent desensitization of mGluR1 was demonstrated in our lab by
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multiple experimental methods. Expression of a catalytically inactivate mutant of GRK2K220R still attenuated mGluR1 signalling (Dale et al., 2000). Furthermore, Dhami et al.
(2002) used an mGluR1 mutant with a truncated C-terminal tail, which prevented GRK2
phosphorylation but not desensitization. These findings suggest that it is the regulators of
G protein signaling (RGS) homology (RH) domain of GRK2 and not the catalytic domain
that mediates mGluR-Gαq/11 uncoupling. GRK2 attenuates receptor signalling by binding
the receptor, Gαq/11 and Gβγ simultaneously (Ferguson, 2007; Tesmer et al., 2005). GRK2
interacts with mGluR1 at the second intracellular loop and the C-terminal tail. Mutation of
either amino acid residues Lys 691 and Lys 692 within the second intracellular loop
disrupts interaction as well as desensitization of the receptor by GRK2 (Dhami et al.,
2005). However, GRK2 regulation of mGluR5a appears to be phosphorylation dependent
and that a residue in the C-terminal tail T840 seems to be important for the interaction
(Sorensen and Conn, 2003). Phosphorylation-independent desensitization, although not
prototypic, is possible for other GPCRs such as follicle-stimulating hormone receptor,
5HT1b receptor and the parathyroid hormone receptor (reviewed in Ferguson, 2007).

1.3.2 Constitutive internalization of mGluRs
Group 1 mGluRs constitutively internalize in an agonist, phosphorylation, and
GRK2-independent manner (reviewed in Dhami et al., (2006)). There is some conflict in
the literature about whether β-arrestin is required for this constitutive internalization. Dale
et al. (2001a, b) reported β-arrestin- and dynamin-independent constitutive internalization,
whereas Pula et al. (2004) reported a β-arrestin-dependent mechanism. However, both
groups agree that constitutive internalization of mGluR1a occurs through clathrin-coated
vesicles. The role of clathrin in mGluR5 constitutive internalization is unclear. Fourgeaud
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et al. (2003) reported that mGluR5a internalizes in a clathrin-independent mechanism.
However, Dale et al. (2001a,b) and Bhattacharya et al. (2004) found significant
colocalization of mGluR1a and 5a with clathrin in endocytic vesicles. Together these
findings suggest that both clathrin-dependent and -independent mechanism contribute to
mGluR1/5 internalization. Bhattacharya et al. (2004) found that Ral (small GTP-binding
protein), Ral guanine nucleotide dissociation stimulator (RalGDS) and PLD2 play a role in
mGluR1/5 constitutive internalization. RalGDS is common to both agonist-dependent and
-independent internalization (Bhattacharya et al., 2002; Bhattacharya et al., 2004).
Ral/PLD2 act as an adaptor for constitutive internalization, whereas β-arrestin acts as an
adaptor for agonist-stimulated internalization. Recruitment of β-arrestin by Ral-GDS in
agonist-independent endocytosis may explain the finding of Pula et al. (2004) of β-arrestindependent constitutive internalization. Moreover, group 1 mGluRs can undergo multiple
mechanisms of endocytosis, each contributing to the complex role that mGluRs play
receptor signalling.

1.4 Regulation of mGluRs by interacting proteins
In addition to proteins that contribute to receptor endocytosis, receptor interaction
with regulatory molecules further tunes the complex process of receptor signalling
(reviewed in Magalhaes et al. (2012); Ritter and Hall (2009)). RGS proteins increase the
GTP hydrolysis rate on the Gαi/o and Gαq/11 subunits of the heterotrimeric G protein
complex. This diminishes the signalling capacity of these G protein-regulated signalling
pathways (reviewed in Hollinger and Hepler (2002)). More specifically, RGS2 and RGS4
have been implicated in regulation of group 1 mGluRs. RGS2 alters mGluR1a-mediated
inhibition of Ca2+ currents and M-type potassium currents (Kammermeier and Ikeda,

14

1999). RGS4 inhibits receptor-mediated ion currents by blocking mGluR1a and mGluR5amediated activation of PLCB by Gαq/11 (Saugstad et al., 1998).
G protein-independent interacting proteins
Scaffolding proteins play an indirect role in GPCR signalling. They facilitate
protein-signalling pathways by tethering interacting proteins in close proximity to one
another thereby increasing the chances of interaction. Many GPCRs are considered to play
a role as scaffolding proteins forming agonist-independent signal transduction complexes,
termed ‘signalsomes’. mGluR interacting proteins include Homer, calmodulin, PDZ
proteins (Tamalin, NHERF-1, NHERF-2, and CAL) (Brakeman et al., 1997; Kitano et al.,
2002; Paquet et al., 2006; Ting et al., 2012).
Perhaps the best characterized scaffolding complex for mGluRs is that of Homer,
IP3R and Shank. The Homer protein family is encoded by 3 genes (Homer1, Homer2 and
Homer3), which yield many Homer isoforms (reviewed in Shiraishi-Yamaguchi and
Furuichi (2007)). All Homer isoforms share an N-terminal EVHI domain, which
recognizes and binds the mGluR as well as the IP3R. Homer1a is the short-protein form;
Homer1b/c, Homer2a/b, Homer3a/b are long-protein forms. Long proteins refer to those
who have a C-terminal coiled-coil domain, which is required for multimerization of
Homers into tetramers. Only long Homer proteins possess the ability to link proteins, such
as mGluR to IP3R. Homer1b proteins bind to mGluR1/5 and IP3R, structurally linking the
two proteins together by Homer multimerization (Tu et al., 1998). Homer 1a protein lacks
the coiled-coil domain and therefore acts as a dominant negative protein to uncouple
mGluR1/5 from the IP3R (Kammermeier, 2008; Kammermeier et al., 2000; Tu et al.,
1998). Homer 1a is an activity-induced isoform that is rapidly up regulated following
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seizure (Brakeman et al., 1997; Ting et al., 2012). Shank proteins coordinate with Homer
proteins to facilitate mGluR1/5 signalling. Shanks crosslink Homer and PSD-95 to cluster
mGluR5 at the PSD (Tu et al., 1999). Shank1b and Homer1b facilitate mGluR1/5mediated Ca2+ signalling (Sala et al., 2005) and induce spine maturation and enlargement
as well as translocation of IP3R to the PSD (Sala et al., 2001). Homer1a reverses these
spine maturation effects (Sala et al., 2003) and also down regulates synaptic AMPARs (Hu
et al., 2010). The Homer-Shank complex provides an example whereby scaffolding
proteins coordinate signalling in a G protein-independent manner.

1.5 Physiological role of group 1 mGluRs
Group 1 mGluRs are mediators of synaptic plasticity as they contribute to both
long-term potentiation (LTP) and LTD by regulation of protein synthesis (Neyman and
Manahan-Vaughan, 2008; Pfeiffer and Huber, 2006). mGluRs play an important role in the
synaptic plasticity that leads to learning and memory, yet dysregulation of these processes
can be manifested as memory related diseases or cognitive impairment. Likewise, these
receptors are implicated in neurodegeneration characteristic of Alzheimer’s Disease (Lee et
al., 2004), excitotoxicity in Huntington’s Disease (Ribeiro et al., 2010), and excessive LTD
characteristic of Fragile X mental retardation syndrome (Bear et al., 2004).
Long-term potentiation
Lomo (1966) first proposed LTP as a mechanism behind learning, acquisition of
new information, and memory, retention of this information. LTP is defined as an activitydependent long lasting increase in synaptic efficacy (reviewed in Lynch, 2004; Malenka
and Bear, 2004). Simply put, LTP is a mechanism of strengthening an active synaptic
connection, thus potentiating future signal transmission at this synapse. There are two
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phases of LTP: Early LTP (E-LTP), which lasts for hours, and long lasting (L-LTP), which
can last for weeks. The basic mechanism of E-LTP is that the activation of NMDAR
increases intracellular Ca2+, leads to CaMKII phosphorylation and the insertion of AMPAR
receptors thereby strengthening the synapse. L-LTP mediates longer-term changes to
synaptic activity through local protein translation and gene regulation. Ionotropic
glutamate receptors (NMDAR and AMPAR) tend to be the focus of much LTP research.
However, mGluRs play an important role in LTP as well and more specifically in the
protein translation required of L-LTP (reviewed in Anwyl (2009)).
mGluR-mediated LTP is generally believed to be ionotropic receptor-dependent.
Recent findings have unearthed ionotropic receptor-independent mGluR-LTP in
interneurons of the hippocampus (Le Duigou and Kullmann, 2011). Here, postsynaptic
mGluR1a activation is necessary for interneuron LTP induction (Lapointe et al., 2004;
Perez et al., 2001). Potentiation of interneurons increases inhibition on pyramidal neurons,
thus providing an adaptive mechanism for regulation of the CA1 pyramidal neurons
(Lapointe et al., 2004). When group 1 mGluRs are activated together with ionotropic
receptors, a higher level of LTP is achieved as compared to ionotropic receptors alone.
Group 1 mGluR’s contribution to LTP is only triggered with prolonged high frequency
stimulation (Wu et al., 2008). This finding together with the perisynaptic localization of
group 1 mGluRs suggests that these receptors are activated by excessive glutamate release
causing spillover to innervate these receptors located outside of the PSD. mGluRs are of
particular importance for late phase and persistence of LTP, whereby mGluRs trigger local,
transcription-independent protein synthesis (Raymond et al., 2000). Furthermore, Job and
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Eberwine (2001) demonstrated that DHPG stimulation could trigger protein synthesis in
dendrites that were isolated from the soma.
Long-term depression
LTD is defined as an activity-dependent long lasting decrease in synaptic efficacy
(reviewed in Bellone et al., 2008; Collingridge et al., 2010; Ito, 1989; Malenka and Bear,
2004). This can include reduced post-synaptic sensitivity to glutamate, reduced synaptic
conductance by internalization of AMPA receptors and reduced individual channel
conductance. There are multiple mechanisms for LTD induction. The two main
mechanisms are NMDA-mediated and mGluR-mediated LTD. These two forms of LTD
can coexist in the same neurons and have specifically been observed together in CA1
pyramidal neurons (Oliet et al., 1997). Unlike NMDAR-mediated LTD, mGluR-mediated
LTD is not easily reversible and may be a precursor to synapse elimination (Bear et al.,
2004; Oliet et al., 1997). Group 1 mGluR-mediated LTD decreases synaptic efficacy
through redistribution and internalization of AMPAR (Snyder et al., 2001). mGluR-LTD
mediates these effects through alterations in local protein translation of pre-existing mRNA
in the dendrites (Huber et al., 2000). A proposed mechanism for translation initiation
requires activation of PI3K, Akt, and mTor (Hou and Klann, 2004). Gallagher et al. 2004
suggests that ERK may play a role the mGluR1/5-mediated alterations in protein synthesis.
Stimulation of either mGluR1 or mGluR5 is sufficient to induce LTD, including reduced
synaptic strength and ERK activation. However, mGluR1 and not mGluR5 is required for
LTD expression and its associated decrease in AMPA receptor expression (Volk et al.,
2006).
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Aberrant mGluR-mediated LTD has been implicated in the pathology of Fragile X
syndrome. Experimentally, mGluR5 knockdown in Fragile X mouse model can reduce
Fragile X phenotypes (Dölen et al., 2007). Additionally, there is currently a phase III
clinical trial underway for the use of an mGluR5 antagonist as treatment for Fragile X (for
results from phase II trials see Jacquemont et al. (2011). In Fragile X syndrome, Fragile X
mental retardation protein (FMRP), which usually represses mRNA translation of specific
proteins, is lost leading to exaggerated LTD in CNS development, specifically in the
hippocampus. Fragile X syndrome is characterized by developmental delay and cognitive
impairment and is a known cause of autism spectrum disorders.
NMDAR-mediated LTD is unaffected in Fragile X mice; however, mGluRmediated LTD is exaggerated. Under normal conditions, mGluR stimulation initiates a
feedback loop that stimulates FMRP translation, which inhibits further mGluR-mediated
protein translation (reviewed Dölen and Bear (2008)). Without FMRP, mGluR signalling is
unchecked, resulting in increased translation of pre-existing mRNA leading to the
exaggerated mGluR-LTD found in Fragile X syndrome. This is supported by Nakamoto et
al. (2007), who described an excessive mGluR5-mediated internalization of AMPAR in
Fragile X.

1.6 Ca2+/calmodulin-dependent protein kinase II
Ca2+/calmodulin-dependent protein kinase II (CaMKII) is a Ca2+-activated enzyme
that has been extensively studied in context with learning and memory since its discovery
(Schulman and Greengard, 1978a, b). Although initially extracted from membranes of
nerve terminals it has since been deemed ubiquitously expressed. It is, however, enriched
in the brain and specifically at the synapses. CaMKII is a serine/threonine kinase whose
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substrates contribute to a wide variety of cellular processes including metabolism, gene
expression, neurotransmitter synthesis and release, cytoskeletal organization, intracellular
Ca2+ homeostasis, membrane current as well as synaptic plasticity by way of long-term
potentiation and long-term depression (Hudmon and Schulman, 2002).
CaMKII is a well-established player in some processes that contribute to learning
and memory. For example, CaMKII is required and sufficient for LTP induction and
spatial learning tasks. CaMKIIα mutant mice were impaired in LTP formation as well as
spatial learning tasks such as Morris Water Maze (Silva et al., 1992a; Silva et al., 1992b).
Furthermore, CaMKII is emerging as a player in LTD. It has recently been implicated in
the protein translation required of mGluR-LTD (Mockett et al., 2011). All together
CaMKII plays a significant role in plasticity of the glutaminergic synapse. It is well
established to regulate ionotropic glutamate signalling and is just starting to be studied in
the context of metabotropic glutamate receptor signalling. Furthermore, CaMKII is
suspected to be a so-called memory molecule. That is, it has been suggested as a molecular
mechanism behind neuronal memory because it possesses a unique ability to
autophosphorylate. Autophosphorylated CaMKII, or autonomous CaMKII, remains
persistently activated after a transient Ca2+ signal. Likewise, CaMKII autophosphorylation
is essential for LTP initiation as NMDA-LTP was abolished in mice expressing mutant
CaMKIIα lacking the ability to be autophosphorylated (Giese et al., 1998).

1.6.1 Distribution and expression
There are 4 genes that express CaMKII (α, β, γ, and δ), which yields 28 similar
isoforms. All isoforms of CaMKII are expressed in the brain; however, α and β are the
predominate isoforms in the brain, while β and δ are predominate in the cerebellum. It is
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the α isoform that will be the focus of this thesis. CaMKIIα constitutes 2% of total protein
in the hippocampus, 1.3% of total cortical protein and 0.7% of total striatal protein
(Coultrap and Bayer, 2012; Erondu and Kennedy, 1985; Hudmon and Schulman, 2002;
Lisman et al., 2002). Within the brain, CaMKII is highly expressed at the synapse and
specifically at the Post Synaptic Density (PSD). CaMKII was initially discovered as a
membrane protein (Schulman and Greengard, 1978a, b), but is now known to be present in
the cytosol as well. Upon activation, CaMKII translocates from the cytosol to the PSD
where it can coordinate processes linked to synaptic plasticity (Hudmon et al., 2005; Strack
et al., 1997). The translocation and activation of CaMKII is specific to the synapse that is
activated (Lee et al., 2009; Zhang et al., 2008).

1.6.2 Structure and functional domains
Each CaMKII subunit is composed of three domains: 1) the N-terminal kinase
domain; 2) the regulatory domain, which contains the autoinhibitory domain,
Ca2+/calmodulin binding domain and important phosphorylation residues Thr 286, Thr 305
and Thr 306; and 3) the C-terminal self-association domain (reviewed in (Coultrap and
Bayer, 2012; Hudmon and Schulman, 2002; Lisman et al., 2002)). Twelve individual
subunits associate to form a dodecomeric holoenzyme. The holoenzyme structure has most
simply been compared to the spokes in a wheel. The self-association domains gather at the
wheel’s hub and the N-terminal catalytic domains of each subunit radiate outwards like
spokes. Recently, the crystal structure of CaMKII was published, this confirms and builds
upon the currently understanding of holoenzyme organization (Chao et al., 2011) (Figure
1.3b). Inactivated CaMKII is in equilibrium between two conformations: compact and
extended. In the compact state the kinase domain folds back on the self-association domain
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Figure 1.3. CaMKII regulation. A, Above depicts a single subunit of CaMKII. A
CaMKII subunit is inactivated as the autoinhibitory domain binds and inactivates the active
site of the catalytic domain. Ca2+/Calmodulin binds and activates CaMKII. Its binding
region overlaps the psuedosubstrate region and thus releases the active site allowing
substrate phosphorylation. Additionally, binding of Ca2+/Calmodulin exposes the
autophosphorylation domain located in the autoinhibitory domain (Thr 286 in the alpha
isoform and Thr 287 in other isoforms). Neighboring subunits can phosphorylate CaMKII.
Once autophosphorylated this residue results in a persistently activated CaMKII molecule
(reviewed in Hudmon and Schulman, 2002). B, 12 CaMKII subunits join together to form
a dodecomeric holoenzyme. This enzyme cycles between its extended and compact
conformation. Only in its extended conformation is it accessable to CaM binding and
subsequent autophosphorylation (Lisman et al., 2012).
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yielding the regulatory (CaM-binding) domain inaccessible. In the extended conformation,
the kinase domain is stretched out, no longer blocking the regulatory domain, thus
allowing Ca2+/calmodulin to bind. Within the dodecomeric holoenzyme each subunit
individually moves between compact and extended, but a subunit in the extended
conformation that is bound to Ca2+/calmodulin influences the neighboring subunits to also
move into the extended conformation allowing Ca2+/calmodulin to bind. Only when two
subunits are bound to Ca2+/calmodulin can autophosphorylation occur.
Within each subunit, the autoinhibitory domain acts as a psuedosubstrate by
binding and inactivating the active site of the catalytic domain (reviewed in Hudmon and
Schulman

(2002)).

Upon

activation,

Ca2+/calmodulin

binds

overlapping

the

psuedosubstrate region and thus releases the active site allowing substrate phosphorylation.
Additionally, binding of Ca2+/calmodulin exposes the autophosphorylation domain, Thr
286 in CaMKIIα isoform and Thr 287 in other CaMKII isoforms, located in the
autoinhibitory domain, which can be phosphorylated by neighboring subunits (Bradshaw et
al., 2002). Once this residue is phosphorylated, CaMKII is persistently activated, termed
autonomous (Figure 1.3a). After Thr 286 phosphorylation, residues Thr 305, Thr 306
residues within the calmodulin-binding domain can be phosphorylated. Phosphorylation at
either site prevents reactivation of CaMKII by blocking the calmodulin-binding domain.
This phosphorylation opposes the effects of Thr 286 phosphorylation by reducing the
autonomous activity (Pi et al., 2010). Phosphorylation at Thr 305 and 306 are important to
determine if CaMKII contributes to LTD or LTP (see below).
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1.6.3 Regulation of CaMKII activity
CaMKIIα responds to increases in intracellular Ca2+ as it is activated by the
Ca2+/calmodulin complex. Activating increases in intracellular Ca2+ can be achieved at the
glutamatergic synapse by activation of ionotropic receptors, which allows the influx of
extracellular Ca2+. Additionally, CaMKIIα can be activated through Gq-coupled GPCRmediated Ca2+ release (Ng et al., 2010). Once activated CaMKII is free to phosphorylate
downstream substrate targets, some of which will further affect CaMKII activation by
regulating Ca2+ concentrations (IP3R, Ca2+/ATPase, AMPAR and NMDAR) (Hudmon and
Schulman, 2002).
Activated CaMKIIα undergoes autophosphorylation, which can both increase and
decrease CaMKII activity. Autophosphorylation at the Thr 286 residue allows CaMKII to
retain some level of activation after the Ca2+ spike (Colbran and Brown, 2004). Thr 286
phosphorylated CaMKII has been implicated in long-term potentiation and neuronal
plasticity as it triggers translocation to the PSD where it phosphorylates PSD proteins such
as AMPA receptors (Strack et al., 1997). Autophosphorylation at Thr 305 and Thr 306
reduces autonomous activity of CaMKII. It also inhibits binding to PSD and weakens
synapses it could provide a mechanism for LTD regulation by CaMKII (Pi et al., 2010).
Within the PSD, CaMKII binds directly to the NMDA receptor subunit NR2B. The NR2B
subunit binds in the catalytic domain of CaMKII and potentiates CaMKII signalling in two
main ways (Bayer et al., 2001). First, it keeps the enzymatic active site exposed and able to
bind to substrates for phosphorylation. Secondly, it keeps the Thr 286 residue exposed so
that it can be autophosphorylated and thus maintained in its Ca2+/calmodulin-independent
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activated state. The CaMKII-NMDA complex is important for LTP induction and learning
as reviewed in Lisman et al. (2012).
CaMKII is also regulated by endogenous proteins, which negatively regulate its
activity. CaM-KIIN is a naturally expressed CaMKII inhibitor found in the brain. It binds
to the catalytic site of activated or autophosphorylated CaMKII with a high degree of
specificity. It binds in the same location as NR2B, but unlike NR2B it blocks the active site
and prevents substrate phosphorylation (Chang et al., 1998; Coultrap and Bayer, 2011;
Lucchesi et al., 2011). Another protein, α-actinin, also contributes to the regulation of
CaMKII. It mimics calmodulin as it binds to the regulator domain. CaMKII bound to αactinin has limited activity and is Ca2+-independent; however, the α-actinin binding
represses some of the functions of CaMKII and also inhibits activation by Ca2+/calmodulin
(Jalan-Sakrikar et al., 2012). For experimental purposes, specific pharmacological
inhibitors have been developed to inhibit CaMKII activity. Both KN-62 and KN-93 inhibit
Ca2+-dependent activity of CaMKII by blocking calmondulin binding (Sumi et al., 1991)
(Tokumitsu et al., 1990). Autocamtide-2-related inhibitory peptide (AIP) is another
CaMKII inhibitor that is 500 times more potent than KN-93 and, unlike KN-93 or KN-62,
it also inhibits automomously active CaMKII in addition to Ca2+-dependent CaMKII
activity (Ishida et al., 1995).

1.6.4 CaMKIIα regulation of glutamate receptors
CaMKIIα plays a significant role in the regulation of the glutamatergic synapse.
Most studied is the relationship between CaMKIIα and the ionotropic glutamate receptors.
However, emerging studies have implicated CaMKII in the regulation of metabotropic
receptors as well. It is well established that CaMKII is required for LTP initiation and
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plays a significant role in its expression. Activated CaMKII translocates from the
cytoplasm to activated synapses (Zhang et al., 2008). Specifically, CaMKIIα has been
shown to translocate in response to NMDAR activation (Hudmon et al., 2005). This
translocation is partially driven by diffusion and by binding to PSD proteins such as the
NR2B subunit of NMDAR (Strack et al., 2000). The direct binding of CaMKII to the
NR2B subunit of the NMDA receptor holds CaMKII in its constitutively active form
(Bayer et al., 2001). This CaMKII-NMDA complex is important for LTP induction as
transgenic mice expressing mutant NR2B subunits, block the CaMKII interaction, and
have impaired LTP (Barria and Malinow, 2005). CaMKII then facilitates synaptic
strengthening by increasing individual AMPA receptor channel conductance by
phosphorylating Ser 831 on the AMPAR GluR1 subunit (Derkach et al., 1999; Lee et al.,
2000). Trafficking of AMPAR to the synapse is positively regulated by the AMPARassociating protein complex Stargazin-PSD95 (Bats et al., 2007). Phosphorylation of
Stargazin triggers AMPAR capture at the synapse (Tomita et al., 2005). CaMKII is shown
to phosphorylate Stargazin in synapses of cultured neurons and may be responsible for
triggering the AMPAR capture characteristic of LTP (Opazo et al., 2010; Tsui and
Malenka, 2006).
Little is known about the role of CaMKII in regulation of mGluR activity.
However, there is mounting evidence that suggests CaMKII may play a significant role in
metabotropic glutamate receptor regulation in addition to ionotropic glutamate receptor
regulation. Mundell et al. 2002 elucidated a novel role for CaMKIIα in activation of
mGluR1 internalization. They found that CaMKII inhibition significantly attenuated
carbachol-induced heterologous mGluR1a internalization. In addition, they found that
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CaMKII inhibition significantly attenuated glutamate-induced homologous internalization
of mGluR1c. Very recently group 1 mGluR activation by DHPG was shown to cause a
transient increase in phosphorylation of CaMKIIα (Mockett et al., 2011). Mockett et al.
also found that CaMKII inhibitors (KN-62, KN-93 and AIP) attenuate DHPG-mediated
LTD and protein synthesis. This suggests a role for CaMKII in group 1 mGluR-dependent
LTD by regulating protein translation.

1.7 Hypothesis
CaMKIIα associates with group 1 mGluRs and this association alters mGluR1/5
signalling and internalization.

1.8 Specific questions
This present thesis builds on preliminary results from a proteomic screen that
elucidated a potential association between group 1 mGluRs and CaMKIIα. We set out to
explore these specific questions to better understand the relationship between group 1
mGluRs and CaMKIIα: 1) Confirm the association between group 1 mGluRs and CaMKII;
2) Examine the effect of CaMKII on group 1 mGluR trafficking; 3) Examine the effect of
CaMKII on mGluR1a signalling.

1.9 Relevance
As discussed previously, CaMKIIα can be phosphorylated by mGluR1/5
stimulation and plays a role in mGluR-LTD, likely through mGluR-mediated protein
translation (Mockett et al., 2011). It is also known that CaMKIIα can alter heterologous
mGluR internalization. However, it is not yet known whether or not mGluR1/5 can
associate with CaMKIIα and if CaMKIIα plays a significant role in receptor signalling and
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homologous internalization. Both CaMKIIα and group 1 mGluRs play an important role in
the maintenance of memory, learning and synaptic transmission. Understanding how these
two players work together is an important bridge to further our current understanding of
post-synaptic modification. This study could also have important implications for
neurodegenerative diseases providing a potential mechanism for reducing excitotoxicity
through desensitization of mGluR1/5 by CaMKII.
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CHAPTER 2
MATERIALS AND METHODS

2.1 Materials
Adult CD-1 mice were from Charles River (Wilmington, MA). Human Embryonic
Kidney (HEK293) Cells were from American Type Culture Collection (Manassas, VA).
Cell culture reagents were from Invitrogen (Burlington, ON): Minimal Essential Media
(MEM), Dulbecco’s Modified Eagle Medium (DMEM), Fetal Bovine Serum (FBS) and
0.25% Trypsin-EDTA. OmniPur Bovine Serum Albumin (BSA) was from VWR
(Mississauga, ON). L-Quisqualic Acid and KN-93 were from Tocris Bioscience
(Minneapolis,

MN).

Biotinylation

reagents

EZ-Link

Sulfo-NHS-SS-Biotin

and

NeutrAvidin Agarose Resin as well as Pierce ECL Western Blotting Substrate and
SuperSignal West Dura Chemiluminescent Substrate were purchased from Thermo
Scientific (Rockford, IL). Myo-[3H]Inositol and Phosphorus-32 Radionuclide were from
Perkin Elmer (Waltham, MA). Protein G Sepharose beads were from GE Healthcare
(Oakville, ON). ANTI-FLAG M2 Affinity Gel and Dowex 1X8 formate 200-400 mesh
resin were from Sigma-Aldrich (St. Louis, MO). DC Protein Assay Kit was from BioRad
Laboratories (Mississauga, ON). Kodak X-Omat Blue Film was from Fisher Scientific
(Ottawa, ON).
Primary Antibodies: CaMKII (G-1) [Santa Cruz Biotechnology (Santa Cruz, CA):
sc-5306]; CaMKII (pan), Phospho-CaMKII (Thr286), CaMKIIα, Phospho-p44/42 MAPK,
p44/42 MAPK [Cell Signaling Technology (Danvers, MA): 3362S, 3361S, 3357S, 9101S,
9102S]; mGluR1 and mGluR5 [Millipore (Billerica, MA): 07-617, AB5675]; GFP
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(Invitrogen: A-6455). Secondary Antibodies: Mouse (GE Healthcare) and Rabbit
(BioRad).
GFP-CaMKIIα construct was from Dr. Paul De Koninck (Laval University,
Quebec, Canada). CaMKIIα shRNA was from Dr. Kenichi Okamoto (Mount Sinai,
Toronto, Canada).

2.2 Cell culturing and transfections
HEK293 cells were used in our investigation because they express a number of
proteins required for mGluR receptor signaling and endocytosis. Specifically they express
GRKs, Arrestins and PKC, which are proteins involved in endocytosis (Atwood, B., 2011).
HEK293 cells were cultured in MEM with 8% FBS. Cells were plated on 100 mm dishes
and transfected using a modified Ca2+ phosphate method (Ferguson and Caron, 2004) with
cDNA amounts indicated in Figure Legends. For transfection, cDNA was diluted to 450
µL in sterile distilled water, 50 µL 2.5 M CaCl2 added, 500 µL 2X HEPES-Buffered Saline
(0.38 M NaCl, 0.05 M HEPES, 1.5 mM Na2HPO4, pH 7.05) added drop-wise and mixed
gently before transfection mixture was added to cells. Cells were washed 16-20 hours post
transfection and then allowed to recover in new media before experimentation. For coimmunoprecipitation, cells recovered for 24 hours. For all other experiments, cells
recovered for 6-8 hours and then were reseeded into 6-well dishes and allowed to recover
for 18 hours.

2.3 Immunoblotting
Acrylamide gels (10%) were run using a Hoefer gel system, and then transferred to
0.45 µM nitrocellulose membrane using a semidry transfer apparatus. Membranes were
blocked for 1 hour in Tris-Buffered Saline and Tween-20 (TBS-T) with 10% milk, and
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then incubated with primary antibody as described, later in the methods, in TBS-T with 5%
milk overnight. Blots were washed with TBS-T, incubated with secondary antibody
(BioRad, Rabbit 1:10,000 and GE Healthcare, Mouse 1:2500) in TBS-T with 5% milk for
1 hour, washed again, treated with ECL Western Blotting Substrate and exposed on film.

2.4 HEK293 cell co-immunoprecipitation
HEK293 cells were transiently transfected with cDNA of FLAG tagged receptor
(mGluR1a or mGluR5a) and either pEGFP (control) or GFP-CaMKIIα (3 µg of receptor
and 0.5 µg of GFP constructs). Cells were stimulated for 0, 2 and 10 minutes with 50 µM
quisqualate in HEPES-Balanced Salt Solution (HBSS: 1.2 mM KH2PO4, 5 mM NaHCO3,
20 mM Hepes, 11 mM Glucose, 116 mM NaCl, 4.7 mM KCl, 1.2 mM MgSO4, 2.5 mM
CaCl2, pH 7.4) at 37°C. Cells were washed on ice with cold Phosphate-Buffered Saline
(PBS: 137 mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4, 1.4 mM KH2PO4, pH 7.2) and then
lysed on a rocking platform for 15 minutes at 4˚C for using 0.1% Triton-X 100 lysis buffer
(0.025 M Hepes, 300 mM NaCl, 1.5 mM MgCl, 0.2 mM EDTA, 0.1% Triton-X) with
added protease inhibitors: 1 mM AEBSF, 10 µg/ml leupeptin, and 5 µg/ml aprotinin.
Lysate was collected and centrifuged at 15,000 RPM for 15 minutes at 4˚C. 250 µg of
each lysate was incubated with FLAG-agarose beads (50 µl bead slurry) for 1 - 2 hours.
Beads were washed three times with cold PBS. Samples were eluted using 3x SDS sample
buffer with 2-mercaptoethanol and separated by SDS-PAGE. Membranes were blotted for
GFP (1:1000) to test co-immunoprecipitation of GFP-CaMKIIα with FLAG-mGluR1/5,
and then immunoblotted for mGluR1 (Millipore, 1:1000) and mGluR5 (Millipore, 1:1000).
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2.5 Hippocampus co-immunoprecipitation
The hippocampus was removed from CD-1 adult mice and placed in 0.5% Triton-X
100 lysis buffer with protease inhibitors. It was then homogenized using a Polytron and
allowed to solubilize for 2 hours while rotating at 4˚C. Lysate was then centrifuged at
15,000 RPM for 15 minutes at 4˚C and 1 mg of protein was incubated with protein GSepharose with mGluR5 antibody (Millipore, 1.5 µg) or Rab11 antibody (control) to
immunoprecipitate mGluR5. Samples were eluted using 3x SDS sample buffer with 2mercaptoethanol and separated by SDS-PAGE.

Membranes were immunoblotted for

immunoprecipitated mGluR5 (Millipore, 1:1000) and co-immunoprecipitated CaMKII
(Santa Cruz, 1:250).

2.6 GST-mGluR1a fusion protein purification and pull-down assay
GST-Fusion protein purification and pull-down assay was conducted similarly to
Dhami et al. (2005). GST-mGluR1a-IL-2 and GST control peptide was generated in E. coli
recombinant bacteria grown at 37°C until OD600 was 0.6-1.0. Cultures were then induced
with 1mM isopropyl 1-thio-β-D-galactopyranoside at 15°C for 2 hours. Cells were pelleted
and resuspended in PBS with (1mM AEBSF, 25 µg/ml Aprotinin, 10 µg/ml Leupeptin, 10
µg/ml Pepstatin A). Sonication (3 times for 30 seconds) at 4°C was then used to lyse the
cells. 1% Triton X-100 was added to the lysate and incubated with rocking at 4°C for 30
minutes. Insoluble materials were pelleted at 12,000 g for 10 minutes at 4°C and the
supernatant containing proteins was aliquoted and stored at -80°C. 50 µl of GlutathioneSepharose bead slurry was incubated overnight with 1 ml of solubilized protein to purify
GST-Fusion constructs. Beads were then washed and resuspended in 100 µl of lysis buffer.
HEK293 cells transiently transfected with GFP-CaMKIIα (0.5 µg cDNA) was lysed and
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centrifuged. For the pull-down assay, GST-Fusion peptide bound to matrix was incubated
with 500 µg of GFP-CaMKIIα HEK293 cell lysate at 4°C for 2-4 hours. Samples were
then washed extensively and eluted using 3x SDS sample buffer containing 2mercaptoethanol. Analysis was done by SDS-PAGE and immunoblotted for CaMKII
(Santa Cruz, 1:250) to determine if GFP-CaMKIIα was pulled down with the GSTmGluR1a peptides.

2.7 Biotinylation internalization assay
Biotinylation internalization assay was conducted similarly to Ferreira et al. (2009).
HEK293 cells were transiently transfected with receptor (FLAG-mGluR1a and FLAGmGluR5a) and either pEGFP (control) or GFP-CaMKIIα (3 µg of receptor and 0.5 µg of
GFP constructs). Cells were serum starved for 1 hour in HBSS at 37°C on the morning of
the experiment. Cells were washed and incubated on ice for 20 minutes in HBSS. Plasma
membrane proteins were biotinylated at 4°C with EZ-Link Sulfo-NHS-SS-Biotin in HBSS
and then incubated at 4°C in 100mM glycine in HBSS for 30 minutes to quench
biotinylation. Cells were then stimulated with 50 µM quisqualate for 0, 5 and 15 minutes,
which allowed the receptor to internalize. Remaining cell surface biotin was stripped using
100 mM sodium 2-mercaptoethanesulfonate (MesNa) in TE Buffer (150 mM NaCl, 1 mM
EDTA, 20 mM Tris, pH 8.6) with 0.2% BSA. A control without stimulation or stripping
was kept on ice and used to assess amount of total cell surface receptor. Cells were lysed,
biotinylated protein pulled down with NeutrAvidin agarose resin (50 µl bead slurry), eluted
with 3x SDS sample buffer containing 2-mercaptoethanol, separated by SDS-PAGE and
immunoblotted for receptors, mGluR1 and mGluR5 (Millipore, 1:1000). Internalization of
the receptor at various time points with and without the presence of over expressed
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CaMKIIα was compared to control. Results expressed as percent cell surface
internalization.
Biotinylation internalization assay was modified slightly for mGluR1a experiments.
Following serum starving, cells were pretreated for 1 hour with or without 1.0 µM KN-93
in HBSS. For stimulation, cells were stimulated with 50 µM quisqualate for 0 and 15
minutes.

2.8 mGluR1/5 ERK1/2 activation
ERK activation assay was conducted similarly to Esseltine et al. (2011). HEK293
cells were transiently transfected with receptor (FLAG-mGluR1a and FLAG-mGluR5a)
and either pEGFP (control) or GFP-CaMKIIα (3 µg of receptor and 0.5 µg of GFP
constructs). Cells were first serum starved overnight in DMEM supplemented with 0.1%
BSA and then serum starved for an additional hour in HBSS on the morning of the
experiment. Cells were stimulated with quisqualate (50 µM) in HBSS at 37°C for 0 or 5
minutes. Samples were washed with cold HBSS and lysed using 1% Triton-X 100 lysis
buffer with protease inhibitors plus phosphatase inhibitors (1 M NaF and 100 µM
Na3VO4). Next, 30-50 µg of each sample were separated by SDS-PAGE. ERK1/2
phosphorylation was determined by immunoblotting for phosphorylated ERK and
compared to total ERK (Cell Signaling, 1:000).

2.9 Inositol phosphate formation
Inositol phosphate formation assay was conducted similarly to Dale et al. (2001b).
HEK293 cells were transiently transfected with FLAG-mGluR1a and either pEGFP
(control) or GFP-CaMKIIα (3 µg of receptor and 0.5 µg of GFP constructs). Cell were
incubated overnight with 1 µCi/ml myo-[3H]inositol in DMEM to radiolabel inositol lipids.
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Cells were washed, and then preincubated in HBSS at 37°C for 1 hour. Cells were then
incubated for an additional 10 minutes at 37°C with 500 µl of HBSS with 10mM LiCl.
Next, cells were incubated with or without quisqualate at increasing concentrations (0-100
µM) for 30 minutes. After stimulation, the reaction was stopped by placing samples on ice
and adding 500 µl 0.8 M perchloric acid, which was neutralized with 400 µl of 7.2 M KOH
and 0.6 M KHCO3. The radioactivity of a 50 µl sample of cell lysate was counted by liquid
scintillation using a Beckman LS 6500 scintillation system to determine the total myo[3H]inositol incorporated into the cells. Anion exchange chromatography, using Dowex
1X8 formate 200-400 mesh resin, was used to extract total inositol phosphate from cells.
[3H]Inositol Phosphate formation was then determined by liquid scintillation using a
Beckman LS 6500 scintillation system.

2.10 Statistical analysis
Immunoblots were quantified using Scion Imaging software. Densitometry values
were normalized for protein expression. GraphPad Prism software was used for statistics
and graph generation. Statistical analysis was performed using a One-way Analysis of
Variance followed by a Tukey’s post hoc test to determine which means were significantly
different (p< 0.05) from one another.
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CHAPTER 3
RESULTS
3.1 CaMKIIα identified as a novel group 1 mGluR associating protein
The intracellular loop (IL) 2 domain of mGluR1a is known to contain a critical
residue for G protein selectivity (Hermans and Challiss, 2001). Our lab has previously
studied CAIN (Ferreira et al., 2009), Pyk2 (Nicodemo et al., 2010) and GRK2 (Dhami et
al., 2004) interactions with this domain. Therefore, we wanted to continue our study of IL2 binding proteins by screening for novel associating proteins to suggest new potential
functions of this important domain. In collaboration with Dr. Stephane Angers, we utilized
a membrane permeant Tat-IL2-FLAG peptide to treat 100 x 108 mouse cortical neurons for
1 hour following which the neurons were solublized, the Tat-IL2-FLAG peptide was
immunoprecipated with FLAG sepharose beads, immunoprecipitates trypsinized and
analyzed by Maldi-TOF Mass Spectroscopy. mGluR1 IL2 interacting proteins identified in
the screen included CaMKII isoforms α, β, γ, and δ as well as other kinases (including
MAPK) and components of endocytotic machinery (including clathrin heavy chain and
dynactin1/2).
Our initial experiments were focused on validating the potential interaction
between CaMKIIα and group 1 mGluRs (mGluR1a and mGluR5a). First, we assessed
whether GFP-CaMKIIα could be co-immunoprecipitated from HEK 293 cells that were
co-transfected to overexpress either FLAG-mGluR1a or FLAG-mGluR5. We found that
GFP-CaMKIIα could be co-immunoprecipitated with FLAG-mGluR1a in the absence of
agonist stimulation (Fig. 3.1A). Moreover, the treatment of the cells with 50 µM
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quisqualate for either 2 or 10 min did not increase the association of GFP-CaMKIIα with
the receptor (Fig. 3.1A). Similarly, GFP-CaMKIIα could be co-immunoprecipitated with
FLAG-mGluR5 in the absence of agonist and agonist treatment did not increase GFPCaMKIIα interactions with FLAG-mGluR5 (Fig. 3.1B). To assess whether endogenous
CaMKII interacts with endogenous mGluR5, we immunoprecipitated CaMKII with a
CaMKII-specific antibody from mouse hippocampal tissue lysates and blotted for
mGluR5. We found that mGluR5 was effectively co-immunoprecipitated with CaMKII
from hippocampal tissue (Fig. 3.2). To confirm that the interaction between CaMKIIα and
mGluR1a/5 was mediated by IL2 we used purified GST-Fusion protein containing the IL-2
portion of mGluR1a and incubated this with HEK293 cell lysate expressing GFPCaMKIIα. We found that GST-IL2, but not GST alone effectively precipitated CaMKIIα
from HEK 293 cell lysates (Fig. 3.3). As a positive control we assessed whether GRK2
could also be precipitated with GST-IL2 and found that similar to that reported by Dhami
et al., (2005) GST-IL2 also precipitates GRK2 from HEK 293 cell lysates (Fig. 3.3). Taken
together these experiments confirm a novel interaction between CaMKIIα and group I
mGluRs, which is mediated by the receptor IL2.

3.2 Role of CaMKIIα in group 1 mGluR internalization
CaMKII regulates heterologous internalization of mGluR1a in response to
activation of the m1 muscarinic acetylcholine receptor (Mundell et al., 2002). Specifically,
Mundell demonstrated that CaMKII inhibition prevented heterologous-stimulated
mGluR1a internalization, but they were unable to demonstrate a significant regulatory role
for CaMKIIα in homologous mGluR1a internalization. In continuation of this work, we
investigated the role of CaMKIIα in homologous internalization of group 1 mGluRs.
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Figure 3.1. Co-immunoprecipitation of GFP-CaMKIIα with FLAG-mGluR1a and
FLAG-mGluR5a. HEK293 cells were transiently transfected as labeled with 0.5 µg of
cDNA mGFP encoding CaMKIIα or pEGFP and 3 µg of pcDNA3.1 encoding (A) FLAGmGluR1a or (C) FLAG-mGluR5a. Cells were stimulated with 50 µM quisqualate then
lysed. Lysates were incubated with mouse FLAG-agarose to immunoprecipitate FLAGtagged receptor. Shown are representative immunoblots for immunoprecipitated receptor
with rabbit anti-mGluR1 or rabbit anti-mGluR5 and for GFP to assess if GFP-CaMKIIα
was

co-immunoprecipitated

with

the

receptor.

B,

D)

Immunoblots

for

co-

immunoprecipitated CaMKII were analyzed by densitometry. Agonist treatments were
compared to unstimulated. p > 0.05. Data are averaged means ± S.E.M. of six independent
experiments.
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Figure 3.2. Co-immunoprecipitation of endogenous CaMKII with mGluR5a in mouse
hippocampal tissue. 1 mg of adult CD-1 mouse hippocampal tissue lysate was incubated
with Protein G-Sepharose and rabbit anti-mGluR5. Samples were analyzed by western
blot. Shown are representative immunoblotted for immunoprecipitated receptor with rabbit
anti-mGluR5

and

co-immunoprecipitated

CaMKII

with

Representative immunoblots of four independent experiments.
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mouse

anti-CaMKII.

Figure 3.3. Purified GST-fusion mGluR1a IL-2 peptide precipitates GFP-CaMKIIα.
Protein purification and lysate preparation: GST-fusion peptides were generated in E. coli
recombinant bacteria, induced with isopropyl 1-thio-β-D-galactopyranoside, sonicated,
centrifuged and purified using Glutathione-Sepharose. HEK293 cells were transiently
transfected with 0.5µg of cDNA mGFP encoding GFP-CaMKIIα. Cells were lysed and
centrifuged. Affinity pull-down assay: GST-Fusion peptides GST-mGluR1a IL-2 and GST
control were each incubated with 500 µg of GFP-CaMKIIα lysate. GRK2 is known to bind
to the IL-2 and is used here as a positive control for IL-2 binding. Samples were analyzed
by western blot. Shown are representative immunoblotted with mouse anti-CaMKII and
rabbit anti-GRK2 to determine if GFP-CaMKIIα and GRK2 was pulled down with the
purified GST-mGluR1a peptide. Representative immunoblots of three independent
experiments.
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3.2.1 CaMKIIα enhances agonist-stimulated mGluR5a internalization
Our initial studies examined whether quisqualate-mediated internalization of
mGluR5a was altered following GFP-CaMKIIα overexpression using a biotinylation
internalization assay. Cell surface proteins were biotinylated on ice, and then warmed to
37°C and stimulated with 50 µM quisqualate for 0, 5 and 15 minutes of stimulation in the
presence or absence of ectopically expressed GFP-CaMKIIα. Internalized mGluR5
following stimulation was compared to total cell surface mGluR5 expression. CaMKIIα
co-expression significantly increased mGluR5a internalization at 15 minutes of agonist
stimulation (Fig. 3.4). mGluR5a co-expressed with GFP-CaMKIIα exhibited a five-fold
increase of agonist-induced loss of cell surface receptor as compared to mGluR5a coexpressed with GFP-control.

3.2.2 CaMKIIα enhances agonist-stimulated mGluR1a internalization
As an extension of our work examining mGluR5a internalization, we tested
whether the CaMKII inhibitor KN-93 would inhibit mGluR1a internalization following 15
min of agonist activation. A biotinylation internalization assay was conducted as described
above except that cells were pretreated with either 1 µM KN-93 or HBSS as a control.
Figure 3.5 shows mGluR1a internalization was increased two fold in the presence of
overexpressed CaMKIIα and this increased internalization was attenuated following KN93 treatment, although the attenuation did not reach a statistically significant value.
Overall, the data supports the conclusion that CaMKIIα overexpression enhances group 1
mGluR internalization and suggests that this may be dependent upon CaMKII catalytic
activity.

41

Figure 3.4. CaMKIIα significantly enhances of mGluR5a internalization at 15
minutes of quisqualate stimulation. A, shown are representative immunoblots for rabbit
anti-mGluR5. HEK293 cells were transiently transfected with 0.5 µg of cDNA mGFP
encoding CaMKIIα or pEGFP and 3 µg of pcDNA3.1 encoding FLAG-mGluR5a. Cell
surface proteins were biotinylated. Cells were stimulated (50 µM quisqualate) and then
biotin was stripped from the cell surface with MesNa (100 mM). Lysates were incubated
with NeutrAvidin-agarose to pull out biotin and associated proteins. B, Immunoblots were
analyzed by densitometry. Internalized mGluR5 was compared to total cell surface
receptor. *, p < 0.05. Data are averaged means ± S.E.M. of four independent experiments
completed in duplicate.
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Figure 3.5. CaMKIIα does not significantly enhance agonist-stimulated mGluR1a
internalization.

A, shown are representative immunoblots for rabbit anti-mGluR1a.

HEK293 cells were transiently transfected with 0.5 µg of cDNA mGFP encoding
CaMKIIα or pEGFP and 3 µg of pcDNA3.1 encoding FLAG-mGluR1a. Cells were
pretreated with or without 1 µM KN-93 for 1 hour. Cell surface proteins were biotinylated.
Cells were stimulated with 50 µM quisqualate for 15 minutes and then biotin was stripped
from the cell surface with MesNa (100 mM). Lysates were incubated with NeutrAvidinagarose to pull out biotin and associated proteins. B, Immunoblots were analyzed by
densitometry. Internalized mGluR1 was compared to total cell surface receptor. p > 0.05.
Data are mean ± S.E.M. of seven independent experiments.
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3.3 Effect of CaMKIIα on mGluR1a signalling
Group I mGluRs are coupled via Gαq/11 to the activation of phospholipase C and
the generation of diacylglycerol and inositol phosphate (IP). CaMKIIα is a kinase that
could contribute to the phosphorylation and desensitization of group I mGluR G protein
coupling. We focused our investigation into mGluR signalling on mGluR1a. Signalling for
this receptor is better established in this lab and therefore allowed us to compare these
results with previous lab data. Therefore, we assessed the role of CaMKIIα in FLAGmGluR1a-stimulated IP formation in HEK 293 cells. We found that the overexpression of
GFP-CaMKII resulted in a statistically insignificant trend of increase in FLAG-mGluR1astimulated IP formation in response to increasing concentrations of quisqualate (Fig. 3.6A),
without affecting basal IP formation in FLAG-mGluR1a expressing cells (Fig. 3.6B). The
treatment of cells with shRNA to knockdown endogenous CaMKIIα expression (Fig.
3.6C) did not result in an alteration in the dose-response curve for quisqualate-stimulated
IP formation in HEK 293 cells transfected to express FLAG-mGluR1a (Fig. 3.6D), and did
not affect basal IP formation (Fig. 3.6E). Furthermore, CaMKIIα shRNA treatment did
not significantly alter FLAG-mGluR1a expression (Fig. 3.6F).

Taken together, these

results indicate that CaMKIIα does not contribute to the regulation of mGluR1a G protein
coupling.
To assess whether CaMKIIα interactions with mGluR1a might alter signalling via
alternative cell signalling pathways, we investigated whether CaMKIIα overexpression
might alter FLAG-mGluR1a-stimulated ERK1/2 phosphorylation.

We found that the

overexpression of GFP-CaMKIIα did not alter FLAG-mGluR1a-mediated ERK1/2
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phosphorylation in response to the treatment of cells with 50 µM quisqualate for 5 min
(Fig. 3.7). Furthermore, treatment of cells with 1 µM KN-93 had no effect on the extent of
FLAG-mGluR1a-stimulated ERK1/2 phosphorylation in either the absence or presence of
overexpressed GFP-CaMKIIα (Fig. 3.7). These results suggest that, similar to G protein
coupling, CaMKIIα does not contribute to the regulation of mGluR1a-mediated ERK1/2
phosphorylation.
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Figure 3.6. CaMKIIα does not have a significant effect on mGluR1a-mediated inositol
phosphate (IP) formation. A, shown is FLAG-mGluR1a-induced IP formation stimulated
with increasing concentrations of quisqualate (0–30 µM) for 30 minutes in the presence of
either GFP (control) or GFP-CaMKIIα. B, shown is basal IP formation without quisqualate
stimulation. HEK293 cells were transiently transfected with 0.5 µg of cDNA mGFP
encoding CaMKIIα or pEGFP and 3 µg of pcDNA3.1 encoding FLAG-mGluR1a. p > 0.05.
Values expressed at mean ± S.E.M. for four-seven independent experiments. C,
representative immunoblots for mouse anti-CaMKII confirms shRNA knockdown of
CaMKII. HEK293 cells were transiently transfected with 3 µg of pcDNA3.1 encoding
FLAG-mGluR1a and with 1 µg of either scramble control or CaMKIIα shRNA 72 hours
before experiment. D, shown is FLAG-mGluR1a-induced IP formation stimulated with
increasing concentrations of quisqualate (0–30 µM) for 30 minutes with or without
CaMKIIα knock down by shRNA. E, shown is basal IP formation without quisqualate
stimulation. F, receptor cell surface expression was analyzed by flow cytometry to confirm
that shRNA treatment did not alter receptor cell surface expression. p > 0.05. Values
expressed at mean ± S.E.M. for four independent experiments.
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Figure 3.7. CaMKIIα does not have a significant effect on mGluR1a-mediated
ERK1/2 phosphorylation. A, shown are representative immunoblots for rabbit anti-phERK1/2 and rabbit anti-total-ERK1/2. HEK293 cells were transiently transfected with 0.5
µg of cDNA mGFP encoding CaMKIIα or pEGFP and 3 µg of pcDNA3.1 encoding
FLAG-mGluR1a. After transfection, cells were serum starved in DMEM overnight and for
an additional hour on the morning of the experiment in HBSS. Cells were stimulated with
50 µM quisqualate for 5 minutes. B, immunoblots were analyzed by densitometry.
Phospho-ERK1/2 compared to total ERK1/2. p > 0.05. C, receptor cell surface expression
was analyzed by flow cytometry to confirm that GFP-CaMKIIα expression did not alter
receptor cell surface expression. Data are mean ± S.E.M. of five independent experiments.
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CHAPTER 4
DISCUSSION
The complex and sometimes controversial relationship between CaMKIIα and
mGluRs is important for the better understanding of mGluR-mediated LTD and related
plasticity. We first identified CaMKIIα as a potential mGluR interacting protein through a
proteomic screen for novel mGluR associating proteins. We hypothesized that CaMKIIα
associates with group 1 mGluRs and this association would alter mGluR1/5 signalling and
internalization. Our studies have revealed several key findings: 1) CaMKIIα associates
with both mGluR-1a and -5a in an agonist independent manner, 2) CaMKIIα enhances
agonist-stimulated internalization of group 1 mGluRs, 3) CaMKIIα does not play a
significant role in group 1 mGluR signalling through either IP3 or ERK1/2
phosphorylation.

4.1 Association between CaMKIIα and group 1 mGluRs
This present thesis demonstrates the novel association of CaMKIIα with group 1
mGluRs. First, we confirmed this association in HEK293 cells (Figure 3.1). We next
replicated this experiment in adult mouse hippocampal tissue (Figure 3.2). This second
experiment showed that the interaction could take place with endogenously expressed
proteins in physiologically relevant tissue. Finally, we confirmed that the second
intracellular loop of mGluR1a is sufficient for the interaction - that it does not require the
full-length receptor (Figure 3.3). This last finding provides new functional significance for
the IL-2 domain. Beyond the bounds of this current thesis we would like to further
characterize this novel interaction. We would localize the specific binding domain within
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the IL-2 required for CaMKIIα association by using four alanine scanning GST-Fusion IL2 peptides similar to that performed in Dhami et al. (2005).
The data suggests that the association between CaMKIIα and mGluRs is agonist
independent, which means that CaMKIIα binds to both the agonist bound and unbound
receptor conformation. Similarly, this brings one to question if the receptor binds
preferentially to activated CaMKIIα. Furthermore, does this interaction have significant
implications for the regulation of CaMKIIα? We know that the interaction of CaMKIIα
with NR2B enhances the autonomously active state of CaMKIIα (Bayer et al., 2001) and
that this CaMKII-NR2B complex is essential for LTP (Barria and Malinow, 2005; Lisman
et al. 2012). Could it be possible that CaMKIIα’s interaction with metabotropic glutamate
receptors could also hold CaMKIIα in a persistently activated state? Mockett et al. (2011)
discussed that CaMKIIα phosphorylation is dynamically regulated by mGluRs. That
mGluRs associate with CaMKIIα could suggest a direct regulation of CaMKIIα activity
and phosphorylation beyond activation by mGluR-mediated Ca2+ release.

4.2 Role of CaMKII in group 1 mGluR internalization
CaMKIIα is known to associate with and contribute to desensitization of ionotropic
glutamate receptors, NMDAR and AMPAR (Colbran and Brown, 2004) and Gαq/11
coupled GPCRs, D1/D2-R (So et al., 2007) and D3-R (Liu et al., 2009). Together, these
findings allow us to reasonably suspect that the association of CaMKIIα with mGluRs
could have similar implications for the mGluR family of receptors. The next goal of this
current thesis was to investigate the role of CaMKIIα in mGluR desensitization.
Our results show that CaMKIIα plays a significant role in agonist-induced mGluR
internalization (Figures 3.4 and 3.5). These results are similar to those found by (Guetg et
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al., 2010) that CaMKIIα significantly enhances agonist-induced internalization of another
class C GPCR, the GABAB receptor. In our results, a more exaggerated enhancement of
receptor internalization was observed for mGluR5a as compared to mGuR1a. This result
for mGluR1a is congruent with previously published findings. Mundell et al. (2002) did
not find a significant difference in glutamate-induced internalization of mGluR1a with
treatment of KN-93, a CaMKII inhibitor; however, he did find significance in the
internalization of the mGluR1c variant. Perhaps this receptor variant dependent difference
could be explained by their structural differences - specifically the length of their Cterminal tail. Mundell et al. (2002) observed that mGluR-1a internalized more slowly than
shorter C-tail splice variants (mGluR-1b and -1c). He did, however, find significant
heterologous internalization for all tested mGluR1 splice variants (mGluR-1a, -1b, and 1c), which he suggested may have to do with a more drastic increase in intracellular Ca2+ to
activate CaMKIIα. Together, these findings suggest that CaMKIIα plays a significant role
in group 1 mGluR internalization; however, this role is more pronounced for shorter tail
variants (mGluR-1c and mGluR-5a). It would be interesting to study the effect of
CaMKIIα on mGluR-1b and -1c variants using a co-expression model compared to
Mundell’s KN-93 inhibition. We predict that the agonist-induced internalization of
mGluR1c would be enhanced by CaMKIIα similarly to our results for mGluR5a.

4.3 Role of CaMKIIα in group 1 mGluR signalling
We moved on to explore the effects of CaMKIIα on mGluR signalling because of
the potential role for CaMKIIα in mGluR signalling attenuation through desensitization.
We also wanted to see if overexpression of CaMKIIα could decrease inositol phosphate
formation because CaMKIIα is known to promote mGluR-IP3R uncoupling by
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phosphorylation of Homer3. CaMKIIα phosphorylates Homer3, which reduced Homer3’s
affinity for its substrates including mGluR1a, phosphorylation of Homer3 changes mGluR
initiated Ca2+ signalling pattern by uncoupling of mGluR1a from the IP3R (Mizutani et al.,
2008). However, we did not find a significant difference between IP3 formation with coexpression of GFP-CaMKIIα compared to GFP control (Figure 3.7).
Furthermore, we found no significant change in ERK1/2 phosphorylation with coexpression of CaMKIIα or with pretreatment by KN-93 (Figure 3.8). Our findings in this
study are contradictory to earlier findings, which state that CaMKIIα inhibitor, KN-62,
decreased DHPG-mediated ERK phosphorylation (Choe and Wang, 2001). It should be
pointed out that we used a different inhibitor KN-93 compared to KN-62. They also used
immunoreactive imaging in rat striatal neurons and we used quantitative western blotting
in HEK293 cell lysates. However, it still remains unclear if CaMKIIα plays a role in
mGluR-mediated ERK signalling and if this is the route to protein synthesis required for
expression of mGluR-LTD. Based on our findings it does not appear that CaMKIIα plays a
significant role in mGluR signalling through either ERK or IP3. Therefore, it would be
interesting to determine whether AKT or mTOR signalling pathways play a role in
mGluR1/5-mediated protein transcription and LTD.

4.4 A potential physiological role of CaMKII in mGluR1a LTD
The relationship between CaMKIIα and mGluR1a-mediated signalling has been
hinted at for sometime; however, conflicting results have delayed its full knowledge
coming to fruition. Choe et al. (2001) published that CaMKIIα mediates DHPG-stimulated
phosphorylation of Elk-1, ERK and CREB. Yet, Schnabel et al. (1999) published that
treatment of CaMKII inhibitor, KN-62, facilitates mGluR-LTD. These two studies are
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contradictory because phosphorylation of Elk-1, ERK and CREB are required for receptor
mGluR-LTD but KN-62 blocks CaMKII’s ability to phosphorylate its substrates. This
topic was further clouded by the larger discussion of the role of Ca2+, an indirect activator
of CaMKII, in mGluR-LTD. Schnabel et al. (1999) went on to rule out Ca2+ as a mediator
of LTD. This was supported by Fitzjohn et al. (2001) and again by Kasten et al. (2012).
Another study showed evidence of Ca2+-dependent mGluR-LTD (Holbro et al., 2009).
Connelly et al. (2011) suggested two forms of mGluR-LTD that are distinctly regulated:
agonist and synaptic. Agonist mGLuR-LTD was regulated by Ca2+ whereas synaptic
mGluR-LTD was not. This could help to explain why sometimes mGluR-LTD is
dependent on Ca2+ and other times it is not. Moreover, mGluR-mediated Ca2+ release is
required for some forms of LTD and also has been shown to activate CaMKIIα. CaMKIIα
is known to be activated by other Gαq/11 coupled GPCRs via IP3-mediated Ca2+ release:
D1/D2-R (Ng et al., 2010). Furthermore, it has recently been found to be activated by
group 1 mGluRs (Mockett et al., 2011) and again through mGluR5 (Moriguchi et al.,
2009).
CaMKIIα plays a role in mediating group 1 mGluR internalization and
desensitization (Mundell et al., 2002). This was again confirmed in our results. In addition,
there is now mounting evidence that implicates CaMKIIα in mGluR1a-mediated protein
translation and eventual expression of synaptic specific LTD (Mockett et al., 2011; Park et
al., 2008). Mockett suggested a role for CaMKIIα in mGluR-mediated protein synthesis
required by LTD through regulating phosphorylation of initiation factor (elF4E). Park
suggested it works through and elongation factor (eEF2). Other studies have suggested that
CaMKIIα plays a role in mGluR-mediated ERK activation in LTD (Choe and Wang,
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2001). Our results showed no CaMKII-mediated change in ERK1/2 phosphorylation. It
remains unclear if CaMKII plays a role in mGluR-mediated LTD through regulation of
protein synthesis. Further studies are required to better understand the relationship between
these two important regulators of synaptic plasticity.

4.5 Summary
This thesis elucidates the novel association between CaMKIIα and group 1
mGluRs. More specifically CaMKIIα interacts within the second intracellular loop of
mGluRs this opens up potential regulatory and functional significance for this domain
among class C GPCRs. From our results it seems that CaMKIIα plays an important role in
receptor internalization. This effect appears to be enhanced in shorter tail variants such as
mGluR5a as compared to mGluR1a.
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